Practical aspects of cardiovascular risk factors identify in patients with diabetes type 1 and 2


Cite item

Full Text

Abstract

The aim of this study was to investigate the characteristics of the risk factors and comparative analysis of different methods of identify of cardiovascular risk factors in outpatient with diabetes mellitus (DM) type 1 and 2.

Methods. In cross-sectional clinical study included 244 persons with type 1 and type 2 mean age 46,4 yrs. All patients were interviewed using a questionnaire of WHO, they were measured blood pressure, heart rate, anthropometric data, including total fat mass with fat analyzer OMRON BF508. All patients were also measured venous and capillary blood glucose level, glycated hemoglobin (%), total cholesterol and triglycerides.

Results. The difference between the two measurement glucose methods (in venous and capillary blood) was 6,7 ± 0,6%. In patients with type 1 diabetes hypertension occurs 2.5 times in less compared with patients with type 2 diabetes. The difference between blood pressure measured by mechanical and automatic devices was less than 1%. The percentage of body fat, including visceral fat, both women and men with type 2 diabetes by age corresponds to the high deviation from the norm. Most men and women with type 1 and type 2 had hypercholesterolemia.

Conclusion. Traditional cardiovascular risk factors are identified, not only among individuals with type 2 diabetes, but among patients with type 1 diabetes.

About the authors

Mehman N. Mamedov

FSBI State Research Center for Preventive Medicine of the Ministry of Health and Social Development of Russia

Author for correspondence.
Email: mmamedov@mail.ru

Head of the Laboratory for Assessment and Correction of the Risk of Chronic Noncommunicable Diseases of the Federal State Budgetary Institution State Research Center for Preventive Medicine of the Ministry of Health and Social Development, Doctor of Medical Sciences, Professor

Russian Federation, Moscow

Marina N. Kovrigina

FSBI State Research Center for Preventive Medicine of the Ministry of Health and Social Development of Russia

Email: Mkovrigina@gnicpm.ru

Junior Researcher, Laboratory for Evaluation and Correction of Cardiovascular Risk, KhNIZ, Department of Epidemiology of Preventive Medicine

Russian Federation, Moscow

Marina B. Buzurtanov

FSBI State Research Center for Preventive Medicine of the Ministry of Health and Social Development of Russia

Email: info@eco-vector.com

Postgraduate student of the Laboratory for Assessment and Correction of Cardiovascular Risk, KhNIZ, Department of Epidemiology of Preventive Medicine

Russian Federation, Moscow

References

  1. Golagiuri. 2006 WHO/IDF Guidelines on the diagnostic criteria for diabetes and impaired glycaemic regulation. Diabetes Medicine. 2006; 23 (Suppl.4): 570
  2. Lloyd C.E., Stephenson J., Fuller J.H. and Orchard T.J. (1996). A comparison of renal disease across two continents; the epidemiology of diabetes complications study and the EURODIAB IDDM Complications Study. Diabetes Care, 19(3), p. 219-225.
  3. Turner R.C., Millns N., Neil H.A. et al. Risk factors for coronary artery disease in non-insulin depend diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS:23) BMJ 1998; 316: 823-28.
  4. Haffner S.M., Lehto S., Rönnemaa T., Pyöralä K., Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. New Engl J Med.1998; 339:229-34.'
  5. Franklin K, Goldberg R.J., Spencer F., Klein W., Budaj A., Brieger D., Marre M., Steg P.G., Gowda N.Gore J.M.; GRACE Investigators. Implications of diabetes in patients with acute coronary syndromes. The Global Registry of Acute Coronary Events. Arch Intern Med. 2004; 164:1457-1463.
  6. DeFronzo R.A., Bonadonna R.C., Ferrannini E. Pathogenesis of NIDDM. A Balanced overview. Diabetes Care 1992; 15: 318-68.
  7. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2004; 27: pl5-35.
  8. Ощепкова E.B., Цагареишвилия E.B., Рогоза A.H. Метод самоконтроля артериального давления (возможности и ограничения) Consilium medicum. 2006. Т.8. №11. С.52-55.
  9. Zimmet Р., Shaw J., Alberti G. Preventing type 2 diabetes and the dysmetabolic syndrome in the real world: a realistic view. Diabetic medicine. 2003; 20(9): 693-702.
  10. Дедов И.И., Шестакова М.В. Сахарный диабет и артериальная гипертензия. М.: МИА. 2006; С. 200-201.
  11. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26:3160-7.
  12. Gallagher D., Heymsfield S.B., Heo M., Jebb S.A., Murgatroyd P.R., Sakamoto Y. Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr. 2000 Sep; 72(3):694-701.

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig 1. Fasting venous blood glucose concentration in individuals with type 1 and type 2 diabetes

Download (41KB)
3. Fig. 2. Waist circumference in men and women with type 1 and type 2 diabetes

Download (40KB)

Copyright (c) 2011 Mamedov M.N., Kovrigina M.N., Buzurtanov M.B.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies